| Study Period | 2019 - 2032 |
| Market Size in 2024 | USD 970.7 Million |
| Market Size in 2025 | USD 1017.3 Million |
| Market Size by 2032 | USD 1506.6 Million |
| Projected CAGR | 5.8% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Market Structure | Fragmented |
Explore the market potential with our data-driven report
The medical crutches market size was USD 970.7 million in 2024, and it will grow by 5.8% during 2025–2032, to reach USD 1506.6 million by 2032
This growth is primarily driven by the expanding geriatric population, the increasing prevalence of mobility-impairing conditions, and the rising number of surgical procedures performed globally. According to research studies, approximately 330 million surgeries are performed each year, creating substantial demand for post-operative mobility aids.
The medical crutches industry growth is significantly influenced by the global demographic shift toward an aging society. By 2030, 1 in 6 people in the world will be aged 60 years or over, with this demographic particularly susceptible to conditions requiring mobility assistance. Moreover, the world is projected to host around 1.6 billion senior citizens by 2050, which makes up about 16% of the world's population. This demographic transformation, combined with the cost-effective nature of crutches compared to other mobility aids such as wheelchairs, positions the market for sustained expansion throughout the forecast period.
Moreover, major factors fueling the market expansion include the increasing number of knee, hip, and joint replacement surgical procedures, the rising number of programs for post-surgery rehabilitation, and their surging use in several conditions like fracture, arthritis, obesity-causing balancing issues, and developmental deformities. In addition, a large number of individuals are affected by non-lethal injuries due to accidents. For instance, around 35 million people suffer from non-lethal injuries globally. Thus, this factor boosts the adoption of crutches.
Furthermore, a scheme called Walking Aids Return Scheme was introduced by King’s College Hospital NHS Trust in April 2025. According to this scheme, patients can return crutches and metal walking sticks at a collection bin outside the Golden Jubilee Wing. Returned items are inspected, cleaned, and repaired. These benefits include reduced waste, cost savings, and better access to mobility aids.
The underarm category held the largest market share, of 40%, in 2024, and it will have the highest CAGR. This is because ease of use makes these crutches a great choice among people, and they are widely used during short-term conditions as most healthcare institutions discharge patients with these crutches. Furthermore, individuals whose legs got amputated and those recuperating from an injury generally use these devices. In comparison to forearm crutches, underarm crutches do not require much upper-body strength and control. Additionally, the rising number of accidents would result in high cases of limb loss, which would eventually increase the need for these crutches.
The products analyzed in this report are:
The broken ankles category held the largest market share, of 25%, in 2024, due to the rising incidence of broken ankles, which results in severe pain and reduced mobility. Additionally, high cost is required to manage this condition in the aging population, hence inexpensive nature of crutches makes them the most suitable and common choice of equipment to be used in this condition. The substantial medical costs associated with ankle fracture treatment, combined with the extended recovery periods requiring mobility assistance, sustain this segment's dominance. Medical crutches provide essential support during the 6-12 week recovery period typical for ankle fractures.
The ACL injuries category will have the highest CAGR, because ACL injuries are excruciatingly painful and greatly restricts one's movement. Irrespective of surgical requirements, the use of crutches significantly aids in healing and regaining mobility. Moreover, this condition requires the usage of crutches for up to 6–9 months.
The conditions analyzed in this report are:
The metal alloys category held the largest market share, of 35%, in 2024, because crutches made of metal alloy have several advantages over others like they are economical, lightweight, adjustable, comfortable, weather-resistant, and durable. In addition, they are suitable for people who have long-term disability, as they are considered the best for long-term use.
The carbon-fiber-reinforced polymer category will have the highest CAGR, because crutches made from such polymers are not only strong but are also extremely light to carry. Additionally, they are flexible and possess high tensile strength due to which they do not break easily and can support more than 140 kg in weight. Hence, due to the above-mentioned reasons, they can be easily used by obese individuals.
The materials analyzed in this report are:
The adults category held the larger market share, of 85%, in 2024, because the majority of individuals belonging to this category suffer from long-term and short-term disability, accidents, and amputations. Moreover, a large number of people belonging to this age group undergo a maximum number of surgical procedures.
The children category will have the higher CAGR, because a large number of children are suffering from some sort of disability. In addition, the World Health Organization has claimed that a prominent cause of mortality among children is road accidents, which are increasing rapidly across the world. Moreover, the rising incidence of childhood obesity, which increases injury risk, combined with greater participation in organized sports activities, contributes to expanding demand in this segment.
The end users analyzed in this report are:
Drive strategic growth with comprehensive market analysis
North America held the largest market share, of 40%, in 2024, due to the presence of top industry players, rising healthcare spending, the existence of a highly advanced healthcare system, robust medical infrastructure, established reimbursement policies and supportive government policies, and the increasing number of patients with disability, in the region. For example, according to the Centers for Disease Control and Prevention, more than 70 million U.S. adults reported having a disability.
Moreover, there is a high prevalence of arthritis in the region. Arthritis significantly impacts one's mobility. For instance, a study has determined that people with arthritis tend to face mobility issues five times more than those who are devoid of it.
Asia-Pacific will have the highest CAGR, of approx. 6.0%, due to the increasing expenditure on healthcare facilities, the surging government initiatives to improve patient care quality, the growing geriatric population, and the rising prevalence of long-term diseases in the region. Moreover, the significant presence of the elderly facilities, the surging government initiatives to improve patient care quality, the growing geriatric population, and the rising prevalence of long-term diseases in the region.
The significant presence of the elderly population base in the growing population of the region is a key factor contributing to the rise in the number of people suffering from disability and the prevalence of chronic illnesses. Additionally, the region is witnessing an increasing number of accidents. For instance, according to the National Police Agency, Japan recorded 307,911 traffic accidents in 2023. Furthermore, the number of people aged 60 and older worldwide is projected to increase from 1.1 in 2023 to 1.4 billion by 2030, with a significant portion of this growth occurring in Asia-Pacific countries.
China represents the largest market within Asia-Pacific, driven by its massive population base and expanding healthcare system. The country's rapidly aging demographic, combined with increasing rates of chronic diseases and improving access to medical devices, positions China for substantial market expansion.
Europe holds a significant market share supported by comprehensive public healthcare systems and strong reimbursement frameworks. Countries in Europe tend to have comprehensive public healthcare systems that subsidize or fully reimburse the cost of essential mobility aids for elderly citizens. National health services, like NHS in the UK and CNAM in France, promote their use through rehabilitation and fall prevention programs, which stimulates regional usage.
Germany leads the European market, benefiting from a robust healthcare infrastructure and high healthcare spending per capita. The country's aging population and comprehensive insurance coverage for medical devices drive consistent demand. The U.K. has a significant market in Europe, with increased focus on community-based care and rehabilitation services supporting market expansion.
Furthermore, the French market shows significant growth during the projected period. This can be due to the presence of top-notch healthcare facilities, which are mainly funded by the national government to provide quality healthcare services to its citizens; and the surging prevalence of chronic illnesses and the number of accidents in the country.
The geographical breakdown of the market is as follows:
The market is fragmented, with numerous regional and international players competing across segments and price points. This fragmentation arises from relatively low barriers to entry in basic crutch manufacturing, diverse regional regulations, and varying consumer preferences across geographies. No single player holds a significant share in the market. The competitive landscape is further shaped by mergers and acquisitions, product innovation, and sustainability initiatives, as companies pursue ergonomic designs, smart technologies, advanced materials, and recycling programs to strengthen their positions and expand reach.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages